Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Engineering interactions between the macrophage polarization and human pluripotent stem cell-derived cardiac tissue to develop an in vitro myocardial infarction model to understand the early disease progression

FY 2012-13

Summary
Cardiovascular diseases are the leading cause of mortality in Canada. Myocardial infarction (MI), also known as a heart attack, occurs when there is a narrowing or a blockage of a blood vessel supplying oxygen and nutrients to the heart. After an MI, the lack of oxygen causes inflammation in the heart muscle that results in scarring. However, the scarred heart tissue is dysfunctional and disrupts normal heart function, eventually leading to heart failure. Very little is known about inflammation occurring in the heart after an MI, and current study tools in the laboratory setting are limited. In this respect, the discovery of a specific type of stem cell has opened an exciting era of potential for MI research. This type of stem cell, called pluripotent stem cell, is capable of giving rise to different cell types of various human organs. In particular, a set of proteins can cause human cells that are already a specific cell type to reverse back into cells that are pluripotent, which has a potential to become any cell type. These generated cells are called human induced pluripotent stem cells (hiPSCs). Our lab has shown that cardiac cells can be derived from hiPSCs. In this study, I propose to use hiPSCs to create an engineered heart tissue (EHT). I will combine EHT with cells that produce inflammation and deprive this system of oxygen, to study how the inflammatory system contributes to the early progression of an MI and scarring. Better understanding of these early events in scarring after a heart attack may lead to the development of pharmaceutical interventions to reduce cardiovascular mortality and improve the quality of life of Canadians.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
275663
Name
Kim Jieun
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Engineering interactions between the macrophage polarization and human pluripotent stem cell-derived cardiac tissue to develop an in vitro myocardial infarction model to understand the early disease progression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cardiac Stem Cell Engineering; Cardiovascular Diseases; Immune System; Inflammatory Response; Myocardial Infarction
Abstract
Cardiovascular diseases are the leading cause of mortality in Canada. Myocardial infarction (MI), also known as a heart attack, occurs when there is a narrowing or a blockage of a blood vessel supplying oxygen and nutrients to the heart. After an MI, the lack of oxygen causes inflammation in the heart muscle that results in scarring. However, the scarred heart tissue is dysfunctional and disrupts normal heart function, eventually leading to heart failure. Very little is known about inflammation occurring in the heart after an MI, and current study tools in the laboratory setting are limited. In this respect, the discovery of a specific type of stem cell has opened an exciting era of potential for MI research. This type of stem cell, called pluripotent stem cell, is capable of giving rise to different cell types of various human organs. In particular, a set of proteins can cause human cells that are already a specific cell type to reverse back into cells that are pluripotent, which has a potential to become any cell type. These generated cells are called human induced pluripotent stem cells (hiPSCs). Our lab has shown that cardiac cells can be derived from hiPSCs. In this study, I propose to use hiPSCs to create an engineered heart tissue (EHT). I will combine EHT with cells that produce inflammation and deprive this system of oxygen, to study how the inflammatory system contributes to the early progression of an MI and scarring. Better understanding of these early events in scarring after a heart attack may lead to the development of pharmaceutical interventions to reduce cardiovascular mortality and improve the quality of life of Canadians.
Competitiondate
201211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kim, Jieun
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2012-13) | Canada Spends